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Pseudorabies virus (PRV), also known as Aujeszky’s dis-
ease, is caused by Suid herpesvirus 1, a member of the 
Alphaherpesvirinae subfamily. Pseudorabies virus is a neu-
rotropic alphaherpesvirus that produces fatal encephalitis in 
newborn pigs, respiratory disorders in fattening pigs, and 
reproductive failure in sows.7 Swine are the natural host of 
PRV, and most domestic animals (cattle, sheep, dogs, cats, 
and goats but not horses) and many wild animals (rats, mice, 
raccoons, opossums, rabbits, and several fur-bearing mam-
mals) are susceptible to infection; death is the usual outcome 
in nonnatural hosts.7 Although pseudorabies was eradicated 
from the U.S. commercial pig industry in 2004, feral swine 
infected with PRV can serve as a wildlife reservoir leading to 
sporadic infections of domestic pigs that may live in close 
contact with feral swine.4 Even though PRV isolates may 
vary in pathogenicity, protection induced by commercial 
PRV vaccines appears to be effective against all wild-type 
PRV.7 An important factor in PRV eradication programs has 
been the use of marker vaccines; for example, in the United 
States, gE-deleted modified live virus vaccines with an 
accompanying gE differential enzyme-linked immunosor-
bent assay (ELISA) were used in combination to eliminate 
wild-type virus–infected swine.6
Maintenance of a PRV-free status involves surveillance 
of susceptible swine. Serological testing for PRV antibody is 
the most common method used for herd diagnosis; it is quite 
efficient and sensitive once the animal has seroconverted. 
However, this testing is insensitive during the acute stages of 
the infection.5 A critical need for the current PRV surveil-
lance program in the United States is the rapid detection of 
PRV infection. Real-time polymerase chain reaction (PCR) 
is a high-throughput test system that has potential to detect 
PRV during the acute phase of the infection or before sero-
conversion. A set of 2 real-time PCR PRV assays detecting 
gB and gE genes and using commercial chemistry has been 
demonstrated to be very effective for the detection and dif-
ferentiation of field and vaccine strains of PRV.3 The PCR 
assay is designed as a dual assay with both gB and gE gene 
targets: gB as a marker for PRV (field isolates, Shope strain, 
and all commercial marker vaccines) and gE as indicator of 
wild-type PRV (positive) or commercial marker vaccine 
strain (negative), with the analytical sensitivity of each assay 
about 0.1 plaque forming units per reaction.3 The aim of the 
present study was to evaluate the real-time gB and gE PCR 
assay for use as a diagnostic assay to detect an acute PRV 
infection in experimentally infected pigs.
Conventionally raised pigs free of clinical disease were 
purchased at 3 weeks of age from a herd that was negative 
for Porcine reproductive and respiratory syndrome virus 
and PRV. They were transported to the National Animal 
Disease Center (NADC) and housed according to NADC 
Institutional Animal Care and Use Guidelines. Pigs were 
randomly assigned to treatment groups and acclimated to 
isolation rooms for 7–10 days before beginning the experi-
ment at 0 days postinoculation (dpi). Three PRV animal 
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Abstract. Pseudorabies virus (PRV) is the cause of Aujeszky’s disease, a disease that is significant economically for the 
swine industry worldwide. A real-time polymerase chain reaction (PCR) assay based on the gB and gE genes was used to 
identify PRV nucleic acid in diagnostic samples. Using virus isolation (VI) as the gold standard, the PCR assay performed well 
in a variety of diagnostic matrices. Testing was conducted on 1,027 nasal swabs with the following findings: gB sensitivity: 
94.6% (95% confidence interval [CI]: 92.3–96.4%), specificity: 71.0% (95% CI: 64.0–77.3%); gE sensitivity: 94.6% (95% 
CI: 92.3–96.4%), specificity: 79.3% (95% CI: 72.9–84.7%). Diagnostic performance of the real-time PCR assay developed as 
a testing method indicates that it is a rapid, accurate assay that can provide reliable results on clinical samples.
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experiments were completed using 178 pigs to study various 
aspects of PRV infection in swine (unpublished observa-
tions, 2010). The duration of the animal studies was sched-
uled for 28, 28, and 7 dpi for experiments 1–3, respectively. 
Depending on experiment, pigs were inoculated with 1 of 4 
PRV isolates or a sham inoculum, and nasal swabsa were col-
lected at selected times to test for PRV. 
Viruses used were feral swine isolate GG150-FS268b 
(hereafter, FS268) isolated from the vaginal tract of a natu-
rally infected free-range feral sow8; feral swine isolate 3CR 
Ossabawc (hereafter, 3CR Os) isolated from a prepuce swab 
of a “healthy” feral swine boar on Ossabaw Island, Georgia; 
feral swine isolate Panther-117c (hereafter, FP-117) isolated 
from a panther presumably infected via contact with feral 
swine1; and a well-characterized domestic swine isolate PRV 
ISUVDL4892d (hereafter, ISU4892) isolated from a case in 
Iowa.9 Each virus was administered intranasally as either a 
“high dose” (approximately 106.3 50% cell culture infective 
dose [CCID
50
]) or a “low dose” (a 1,000-fold dilution of the 
high dose). Each isolate was propagated once in a swine tes-
ticular (ST) cell line in a 75-cm2 plastic flask inoculated with 
0.5 ml of original stock virus. Virus was allowed to adsorb 
for approximately 1 hr followed by a medium change with 
minimal essential medium (MEM)e and then maintained in 
maintenance medium (MEM including 10% fetal bovine 
serum and 50 mg/l gentamicin). When cytopathic effects 
(CPEs) involved 80–90% of the monolayer (24–36 hr post-
inoculation) the flask was frozen and thawed twice at –80°C 
before clarifying the cell culture lysate (1,000 × g for 10 
min). The supernatant was stored in 0.5-ml aliquots at –80°C.
Nasal swab (NS) samples were collected in 2 ml of MEM 
from 0 to 14 dpi for experiments 1 and 2 and from 0 to 7 dpi 
for experiment 3 and stored at –80°C until tested for virus. 
For viral DNA extraction, the sample was thawed, vortexed, 
and centrifuged (652 × g, 4°C, 30 min). All viral DNA was 
extracted from samples using a commercial kit.f After 4 
washes, the DNA was mixed with the elution buffer and kept 
at –80°C until used in the PCR reactions. Real-time PCR 
assays for the detection of gB and gE genes were conducted 
using commercial chemistryg as previously reported.3 
Suspensions of 0.084 µg/ml gB plasmid and 0.023 µg/ml gE 
plasmid3 were used as standards for the respective gB and gE 
real-time PCR assays. Virus isolation (VI) was performed on 
MARC (cloned African green monkey kidney cell line)-145 
cells cultured at 37°C in 5% CO
2
 atmosphere in 24-well 
plastic plates. A confluent monolayer of cells was inoculated 
with 0.1 ml of filtered (0.45 µm) NS sample in a single well. 
After approximately 1 hr postinoculation, the medium was 
changed, and cells were incubated in maintenance medium 
at 37°C in 5% CO
2
 atmosphere for 96 hr, with daily monitor-
ing for development of CPE. Negative samples were blind 
passed 1 time. A random sampling of PRV-positive wells 
was confirmed using PCR. Although all NS samples were 
tested for infectious virus using the MARC-145 cell line, NS 
from experiment 1 had initially been thawed 1 time and 
tested on ST cells before virus isolation on MARC-145 cells.
The sensitivity of the ST and MARC-145 cells for repli-
cating PRV was compared using VI and PCR. For each 
virus, a 20-µl volume of stock challenge virus was inocu-
lated into a 25-cm2 tissue flask containing a monolayer of 
either ST or MARC-145 cells. Approximately 1 hr postin-
oculation, the medium and flasks were incubated at 37°C in 
5% CO
2
 atmosphere for 24 hr, at which time the flask was 
frozen at –80°C and thawed. The lysate was collected and 
clarified at 1,000 × g for 15 min, and a 0.5-ml volume of 
virus solution was dispensed into 2-ml cryovial tubes for 
storage at –80°C. Two vials were thawed for testing (second 
freeze–thaw cycle), and 2 vials were frozen and thawed 3 
additional times before testing (fifth freeze–thaw cycle). 
Each isolate propagated in ST or MARC-145 cells was tested 
for infectious virus by titration of the virus on ST and 
MARC-145 cells. In addition, viral DNA was extracted and 
tested by PCR. Serum samples collected at 0 and 14 dpi were 
tested for PRV antibodies using an ELISA assay,i according 
to manufacturer’s recommendations, where PRV gB ELISA 
optical density sample-to-negative (S/N) ratio <0.60 is posi-
tive, S/N ratio >0.60 to ≤0.70 is suspect, and S/N ratio >0.70 
is negative.
Sensitivity (Se), specificity (Sp), and kappa (κ) coeffi-
cients of agreement were calculated for the real-time PCR 
assay performance compared with results of VI, the gold 
standard test, using contingency tables and Fisher exact test 
(2-tailed) preformed with commercial software.j,k The κ 
coefficient of agreement can take values between 0 and 1, 
where poor agreement κ is <0.20, fair agreement κ = 0.20–
0.39, moderate agreement κ = 0.40–0.59, good agreement 
κ = 0.60–0.79, and very good agreement κ = 0.80–1.00.2
Control animals did not display clinical signs or lesions 
consistent with PRV infection. The PRV-inoculated pigs 
developed a spectrum of disease that ranged from mild to 
severe, which required euthanasia for humane reasons. 
Clinical signs observed included sneezing, anorexia, listless-
ness, increased respiration rates, dyspnea, rough-haired 
appearance, and loss of condition. The onset, magnitude, and 
duration of clinical signs were variable among pigs within a 
group and between groups inoculated with different viruses 
and seemed related to challenge dose (i.e., the groups that 
received the “high” dose had more virus-positive and 
affected pigs compared with the “low” dose groups). 
Moreover, there appeared to be differences in the pathoge-
nicity of the viruses, with the ISU4892 being the most patho-
genic followed by the FP-117, 3CR Os, and FS268 isolates, 
in that order. Mortality following inoculation did occur in 
some groups and is reflected in the reduction of pig numbers 
(decrease in the denominator) shown in Table 1.
The MARC-145 cell line was chosen for VI because 1) 
the cells consistently grew better compared with ST cells in 
the laboratory, making the process of VI on hundreds of 
  
741
T
ab
le
 1
. D
et
ec
tio
n 
of
 P
se
ud
or
ab
ie
s v
iru
s i
n 
na
sa
l s
w
ab
s b
y 
re
al
-ti
m
e 
po
ly
m
er
as
e 
ch
ai
n 
re
ac
tio
n 
(P
C
R
) a
ss
ay
 a
nd
 v
iru
s i
so
la
tio
n 
(V
I)
.
D
ay
 p
os
tin
oc
ul
at
io
n 
w
he
n 
sa
m
pl
e 
w
as
 c
ol
le
ct
ed
 
2
4
7
9
11
14
St
ra
in
 
do
se
gB
 P
C
R
gE
 P
C
R
V
I
gB
 P
C
R
gE
 P
C
R
V
I
gB
 P
C
R
gE
 P
C
R
V
I
gB
 
PC
R
gE
 
PC
R
V
I
gB
 
PC
R
gE
 
PC
R
V
I
gB
 
PC
R
gE
 
PC
R
V
I
FS
26
8
 
Lo
w
6/
7
5/
7
6/
7
7/
7
7/
7
7/
7
5/
7
5/
7
3/
7
4/
6
4/
6
0/
6
2/
6
1/
6
0/
6
0/
6
0/
6
0/
6
 
H
ig
h
7/
7
7/
7
7/
7
7/
7
7/
7
7/
7
7/
7
7/
7
5/
7
4/
7
3/
7
1/
7
2/
7
2/
7
0/
7
1/
7
1/
7
0/
7
3C
R
 O
s†
 
Lo
w
2/
7
2/
7
2/
7
4/
7
4/
7
5/
7
4/
7
4/
7
0/
7
2/
7
2/
7
0/
7
1/
7
1/
7
0/
7
0/
7
0/
7
0/
7
 
H
ig
h
10
1/
10
6
99
/1
06
94
/1
06
98
/1
06
94
/1
06
10
1/
10
6
99
/1
02
10
0/
10
2
99
/1
02
4/
5
3/
5
2/
5
0/
5
0/
5
0/
5
0/
5
0/
5
0/
5
IS
U
48
92
 
Lo
w
2/
7
0/
7
0/
7
1/
7
0/
7
7/
7
1/
7
1/
7
0/
7
1/
7
1/
7
0/
7
0/
7
0/
7
0/
7
0/
5
0/
5
0/
5
 
H
ig
h
5/
7
5/
7
5/
7
7/
7
7/
7
7/
7
1/
2
1/
2
1/
2
1/
1
1/
1
0/
1
1/
1
1/
1
0/
1
1/
1
1/
1
0/
1
FP
-1
17
 
Lo
w
4/
10
4/
10
5/
10
9/
10
8/
10
10
/1
0
10
/1
0
10
/1
0
10
/1
0
9/
10
9/
10
9/
10
7/
10
6/
10
3/
10
0/
10
0/
10
0/
10
 
H
ig
h
10
/1
0
10
/1
0
10
/1
0
10
/1
0
10
/1
0
10
/1
0
8/
10
10
/1
0
10
/1
0
10
/1
0
10
/1
0
8/
10
6/
10
6/
10
5/
10
0/
10
0/
10
0/
10
Pe
rc
en
t  
  p
os
iti
ve
‡
85
%
 
(1
37
/1
61
)
82
%
 
(1
32
/1
61
)
80
%
 
(1
29
/1
61
)
89
%
 
(1
43
/1
61
)
85
%
 
(1
37
/1
61
)
96
%
 
(1
54
/1
61
)
89
%
 
(1
35
/1
52
)
91
%
 
(1
38
/1
52
)
84
%
 
(1
28
/1
52
)
64
%
 
(3
5/
53
)
62
%
 
(3
3/
53
)
38
%
 
(2
0/
53
)
36
%
 
(1
9/
53
)
32
%
 
(1
7/
53
)
15
%
 
(8
/5
3)
4%
 
(2
/5
1)
4%
 
(2
/5
1)
0%
 
(0
/5
1)
* 
En
tri
es
 in
di
ca
te
 th
e 
nu
m
be
r o
f p
os
iti
ve
s/
to
ta
l n
um
be
r o
f p
ig
s i
n 
gr
ou
p.
 F
S2
68
 =
 fe
ra
l s
w
in
e 
is
ol
at
e 
G
G
15
0-
FS
26
8b
 is
ol
at
ed
 fr
om
 th
e 
va
gi
na
l t
ra
ct
 o
f a
 n
at
ur
al
ly
 in
fe
ct
ed
 fr
ee
-r
an
ge
 fe
ra
l s
ow
; 3
C
R
 O
s =
 
fe
ra
l s
w
in
e 
is
ol
at
e 
3C
R
 O
ss
ab
aw
c 
is
ol
at
ed
 fr
om
 a
 p
re
pu
ce
 sw
ab
 o
f a
 “
he
al
th
y”
 fe
ra
l s
w
in
e 
bo
ar
 o
n 
O
ss
ab
aw
 Is
la
nd
, G
eo
rg
ia
; I
SU
48
92
 =
 w
el
l-c
ha
ra
ct
er
iz
ed
 d
om
es
tic
 sw
in
e 
is
ol
at
e 
PR
V
 IS
U
V
D
L4
89
2d
 
is
ol
at
ed
 fr
om
 a
 c
as
e 
in
 Io
w
a;
 F
P-
11
7 
= 
fe
ra
l s
w
in
e 
is
ol
at
e 
Pa
nt
he
r-1
17
c 
is
ol
at
ed
 fr
om
 a
 p
an
th
er
 p
re
su
m
ab
ly
 in
fe
ct
ed
 v
ia
 c
on
ta
ct
 w
ith
 fe
ra
l s
w
in
e.
† 
St
ra
in
 3
C
R
 O
s a
t a
 h
ig
h 
do
se
 w
as
 a
ls
o 
sa
m
pl
ed
 a
t 6
 d
pi
 re
su
lti
ng
 in
 9
3/
99
 (9
4%
), 
89
/9
9 
(9
0%
), 
an
d 
98
/9
9 
(9
9%
) s
am
pl
es
 p
os
iti
ve
/to
ta
l n
um
be
r o
f p
ig
s f
or
 g
B
 P
C
R
, g
E
 P
C
R
, a
nd
 V
I, 
re
sp
ec
tiv
el
y.
‡ 
Pe
rc
en
ta
ge
 p
os
iti
ve
 o
ut
 o
f t
ot
al
 te
st
ed
 (n
um
be
r p
os
iti
ve
/n
um
be
r t
es
te
d)
.
  
742 Zanella et al.
samples much more efficient; 2) PRV infection of MARC-
145 cells induced a dramatic CPE consisting of large forma-
tions of syncytia that were easily observed; and 3) under the 
conditions of the current study, the MARC-145 cells were as 
sensitive or more so for PRV isolation compared with ST 
cells (Table 2). Compared with ST cells, the CPE for each 
PRV isolate that developed in MARC-145 cells following 
inoculation was more rapid and extensive by 24 hr, the time 
of freezing for each flask. However, the viral titers produced 
in either cell line were similar for each virus despite the cell 
line in which the virus was propagated (Table 2). Likewise, 
the quantitative PCR results were similar for viruses pro-
duced in ST or MARC-145 cells (Table 2). A suspension of 
field isolate PRV strains FS268, 3CR Os, and ISU4892, and 
plasmid, as well as serial dilutions in MEM, were tested in 
duplicate to determine real-time PCR assay sensitivity 
(Table 3). The real-time PCR assay was able to detect a 
range of positive dilutions (up to 10-5 using MEM as dilu-
ent). Concentrations of 102.2 CCID
50
/ml FS268, 101.7 CCID
50
/
ml 3CR Os, and 101.9 CCID
50
/ml ISU4892 were detected 
(Table 4). Because of the small size of the PCR product, 
sequencing was not performed; however, size of the product 
was consistent among samples tested. In general, the gB 
threshold cycle values were lower than those from the gE 
PCR. A sample was classified positive if at least 1 duplicate 
tested positive for the following gB or gE PCR results.
A total of 1,027 NS were collected from 0 to 14 dpi and 
tested for infectious virus; 136 NS were from 17 control pigs 
and 891 NS were from PRV-inoculated pigs. All samples 
from control pigs and the 0 dpi NS collected from the PRV-
inoculated pigs were negative for infectious virus, a total of 
297 NS samples (data not shown). Pseudorabies virus was 
Table 2. Analytical comparison of Pseudorabies virus propagation in ST (swine testicular) cell line and MARC (cloned African green 
monkey kidney cell line)-145 cells by virus titration and by virus isolation via real-time polymerase chain reaction assay on ST or MARC-
145 cells.*
MARC-145 ST MARC-145 ST
 MARC-145† ST MARC-145 ST gB‡ gE gB gE
FP-117
 F-T 2 7.12 5.58 6.88 5.70 4.48 5.22 5.01 5.52
 F-T 5 6.63 5.42 6.58 5.50 5.25 5.89 5.59 6.20
3CR Os
 F-T 2 6.12 5.42 6.12 5.63 4.42 4.86 4.80 5.08
 F-T 5 5.62 4.47 5.58 4.12 4.62 5.02 5.21 5.57
FS268
 F-T 2 7.16 5.58 4.88 4.30 4.63 5.22 4.34 4.76
 F-T 5 5.42 5.30 3.58 3.16 4.95 5.39 4.66 4.78
ISU4892
 F-T 2 7.16 6.58 6.30 5.58 5.09 5.67 4.99 5.53
 F-T 5 6.50 6.30 4.88 4.50 5.54 6.00 5.75 6.11
* Two vials were thawed for testing (F-T 2) and 2 vials were frozen and thawed 3 additional times before testing (F-T 5). Sham samples at second and fifth 
freeze–thaw cycles were negative in all tests. FP-117 = feral swine isolate Panther-117c isolated from a panther presumably infected via contact with feral 
swine; 3CR Os = feral swine isolate 3CR Ossabawc isolated from a prepuce swab of a “healthy” feral swine boar on Ossabaw Island, Georgia; FS268 = 
feral swine isolate GG150-FS268b isolated from the vaginal tract of a naturally infected free-range feral sow; ISU4892 = well-characterized domestic swine 
isolate PRV ISUVDL4892d isolated from a case in Iowa.
† log10 50% cell culture infective dose/100 µl.
‡ log10 copy number/100 µl.
Table 3. Detection limits and threshold cycle (Ct) values of 
real-time polymerase chain reaction assay for Pseudorabies virus 
standards.
Ct value
gB copy per reaction
 5.75 × 107 17.2
 5.75 × 106 19.9
 5.75 × 105 23.1
 5.75 × 104 26.5
 5.75 × 103 30.3
 5.75 × 102 33.6
 5.75 × 101 36.6
gE copy per reaction
 1.63 × 108 14.7
 1.63 × 107 15.1
 1.63 × 106 17.1
 1.63 × 105 19.8
 1.63 × 104 23.0
 1.63 × 103 25.4
 1.63 × 102 29.5
 1.63 × 101 33.5
 1.63 × 100 38.6
 1.63 × 10-1 Undetected
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isolated from 537 of the 730 NS collected 2–14 dpi from the 
161 PRV-inoculated pigs (Table 1). The incidence of posi-
tive NS ranged from 80% at 2 dpi to 0% at 14 dpi with a peak 
of 99% at 6 dpi (Table 1). When individual challenge groups 
were compared, the incidence of positive NS was similar 
among groups, with apparent differences related to challenge 
dose. Due to relatively small animal numbers in some of the 
groups, statistical analysis was not applied to the incidence 
of positive NS among groups.
A total of 1,027 NS were tested with the gB and gE real-
time PCR assays. For VI, 136 NS were from 17 control pigs 
and 891 NS were from PRV-inoculated pigs. All samples 
from control pigs tested negative by the gB and gE assays. 
One of the 161 NS samples collected from the PRV-
inoculated pigs at 0 dpi tested positive by gB and gE, and the 
remaining 160 NS samples at 0 dpi tested negative by both 
gB and gE assays. Collectively, 296 of the 297 NS samples 
collected from the control pigs and the PRV-inoculated pigs 
at 0 dpi were negative by PCR (data not shown). The single 
PCR-positive 0 dpi sample that tested positive by gB and gE 
retested positive by the gB and gE assays and was negative 
by VI. Of the NS collected from 2 to 14 dpi from the PRV-
inoculated pigs, 564 of 730 and 548 of 730 samples tested 
positive by the gB and gE assays, respectively (Table 1).
To evaluate the Se, Sp, and κ agreement for the gB and gE 
PCR assays, VI was used as the gold standard test. Overall, 
73.6% of the swab samples tested positive by VI, and 77.3% 
and 75.1% tested positive by the gB and gE PCR assays, 
respectively. The Se, Sp, and κ values (Table 5) show a good 
agreement between the assays despite a higher percentage of 
positive samples in the PCR assays compared with VI. Most 
of the difference between the PCR-positive and VI-positive 
samples was detected at 9–14 dpi, with more samples being 
PCR positive than VI positive (Table 1). This is in contrast to 
2–7 dpi, where more samples were VI positive than PCR 
positive, indicating a higher likelihood to isolate virus during 
the first week postchallenge compared with the second week.
Based on the ELISA, all PRV-inoculated pigs were sero-
positive by 14 dpi (mean S/N 0.26 ± 0.2) All control pigs for 
the duration of the study as well as all 0 dpi sera were nega-
tive (mean S/N 1.22 ± 0.03) for PRV gB antibody.
A variety of methods can be used to detect PRV infection 
in swine. Selecting a method or methods to use may be based 
on a number of factors (e.g., available equipment and 
reagents, the need to detect acute or chronic infections, and 
the necessity to screen large numbers of samples for anti-
body, antigen, infectious virus, or viral nucleic acid). In 
PRV-free swine herds, detection of antibody is a very effi-
cient and reliable tool to monitor PRV status.7 A limitation 
of this type of testing is the potential to miss positive animals 
because they have not yet seroconverted. The potential of a 
real-time PCR test to detect PRV during the acute phase of 
infection was evaluated at a time when pigs would be devel-
oping a humoral response and thus would be seronegative by 
currently available antibody tests.
The acute nature of the PRV infection observed in experi-
ments 1–3 is demonstrated in Table 1 with isolation of infec-
tious PRV by 2 dpi in most inoculated pigs and in 99% of the 
pigs at 6 dpi. The incidence of VI-positive pigs decreased to 
0% by 14 dpi, a time when all surviving animals have become 
Table 4. Detection limits and threshold cycle (Ct) values of 
real-time polymerase chain reaction assay for Pseudorabies virus 
field samples.
Ct value
Strain
Infectious virus per 
reaction (CCID
50
) gB gE
FS268 40 30.9 28.8
  4 34.5 32.5
 0.4 38.6 36.0
 0.04 Undetected 39.2
3CR Os 12.5 31.2 29.5
 1.25 34.7 33.2
 0.125 38.2 36.7
 0.0125 Undetected Undetected
ISU4892 19.8 31.6 29.7
 1.98 35.4 33.3
 0.198 38.8 37.7
 0.0198 Undetected Undetected
* FS268 = feral swine isolate GG150-FS268b isolated from the vaginal 
tract of a naturally infected free-range feral sow; 3CR Os = feral swine 
isolate 3CR Ossabawc isolated from a prepuce swab of a “healthy” feral 
swine boar on Ossabaw Island, Georgia; ISU4892 = well-characterized 
domestic swine isolate PRV ISUVDL4892d isolated from a case in Iowa; 
CCID
50
 = 50% cell culture infective dose; undetected = no signal for a 
cycle threshold below 40.
Table 5. Overall results, sensitivity (Se), specificity (Sp), and 
kappa (κ) degree of agreement for real-time polymerase chain 
reaction (PCR) assay versus virus isolation (VI) for Pseudorabies 
virus collected by nasal swab.*
VI
Test + – Total
gB PCR
 + 508 56 564
 – 29 137 166
 Total 537 193 730
 Se 94.6% (95% CI: 92.3–96.4%)
 Sp 71.0% (95% CI: 64.0–77.3%)
 κ 0.687 (0.625–0.748)
gE PCR
 + 508 40 548
 – 29 153 182
 Total 537 193 730
 Se 94.6% (95% CI: 92.3–96.4%)
 Sp 79.3% (95% CI: 72.9–84.7%)
 κ 0.752 (0.697–0.808)
* + = positive; – = negative; 95% CI = 95% confidence interval.
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antibody positive. The incidence of PCR-positive pigs mir-
rors the VI data with slight temporal differences  in which 
the incidence of VI-positive pigs is similar to or greater than 
PCR-positive pigs during the first week of infection and the 
incidence of PCR-positive pigs is greater than VI-positive 
pigs during the second week of the infection.
Real-time PCR assays have been developed and standard-
ized for the detection of wild-type PRV using the gB gene 
target and the gE gene to differentiate from vaccine virus.3 In 
the present study, the real-time PCR assays were evaluated 
for diagnostic and surveillance potential and showed a high 
sensitivity that detected the viral genome in every inoculated 
pig. Utilization of a real-time PCR assay eliminates the 
requirement of separate amplification and detection reac-
tions associated with gel-based techniques. Compared with 
conventional PCR, real-time PCR assays based on fluoro-
genic probes have additional advantages, including improved 
sensitivity that is based on very short amplification products 
and results in increased specificity, simultaneous detection 
of relevant PCR products using multichannel analysis, and 
reduction of cross-contamination through absence of post-
PCR handling of product.
The higher sensitivity of the real-time PCR assays com-
pared with VI assays was demonstrated in the present study. 
The real-time PCR assay as described3 detected a number of 
various PRV strains including feral and domestic from dif-
ferent geographical regions. The potential for false-positive 
or false-negative results is a risk associated with any 
amplification-based assay, including real-time PCR. In the 
current study, 1 PCR false-positive was easily detected 
because it was found in a sample collected at 0 dpi. This 
sample was still positive by both PCR assays upon retest but 
was negative by VI. Although it is not known why this sam-
ple was PCR positive, a technical mistake is presumed to 
have been made (i.e., a mistake in tube labeling). Nevertheless, 
there was 1 known PCR-positive sample of 298 samples that 
should have all been negative because they were either col-
lected from nonchallenge control pigs or collected prior to 
challenge (0 dpi) in the challenge pig groups. It is not possi-
ble to assess the potential for false-positive results in the 
PRV-challenged pigs because all pigs were considered posi-
tive (i.e., virus was isolated [gold standard] at least 1 time 
from each challenge pig, at least 1 NS sample was PCR posi-
tive for each pig, and all pigs alive at 14 dpi were seroposi-
tive). Although each PRV-inoculated pig was deemed PRV 
positive, not all samples tested from each pig were positive 
(Table 1). It is believed that the detection of negative sam-
ples in the virus-challenged animals reflects more upon the 
host response to the disease and not a false-negative rate of 
approximately 25% overall.
Collectively, results from these studies indicate that 
natural infection of domestic swine with feral swine PRV 
isolates should be detected either through detection of 
virus during the acute phase of the infection or through 
detection of antibody in the convalescent phase of the 
infection. This conclusion supports many current control 
programs that screen sera for PRV-specific antibody and 
that may consider incorporating testing tissues for virus by 
real-time PCR.
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